These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29497929)

  • 1. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
    Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
    J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
    Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
    Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
    Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study.
    Ahadi M; Moradi A; Musavinejad L; Movafagh A; Moradi A
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1607-1614. PubMed ID: 32592354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.
    Schizas D; Moris D; Kanavidis P; Michalinos A; Sioulas A; Pavlakis K; Machairas A; Liakakos T
    In Vivo; 2016 11-12; 30(6):939-944. PubMed ID: 27815484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
    Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
    Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer.
    Kurozumi K; Nishida T; Nakao K; Nakahara M; Tsujimoto M
    World J Surg; 1998 Aug; 22(8):853-7; discussion 857-8. PubMed ID: 9673558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
    Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
    J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
    Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
    BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
    Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
    Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected proliferation markers correlated with dynamics of growth in colorectal cancer.
    Luo WX; Chen Y; Li YT; Tang J; Ding J; Du Y; Wu Q; Liu JY
    Eur J Cancer Prev; 2019 May; 28(3):181-187. PubMed ID: 29688906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma.
    Acikalin MF; Etiz D; Gurbuz MK; Ozudogru E; Canaz F; Colak E
    Med Oncol; 2012 Jun; 29(2):742-9. PubMed ID: 21553103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
    Wu CT; Lin WY; Chen WC; Chen MF
    Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
    Lu G; Wu X; Zhou L; Yu L; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.
    Feakins RM; Nickols CD; Bidd H; Walton SJ
    Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.